Replies to post #243429 on Biotech Values

[DewDiligence]

Are we looking at another CRL followed by another six months delay or more?

Highly unlikely, IMO.

Given we now know that the FDA has closed out all of the 2021 manufacturing deficiencies, the probability of FDA approval in the near future is higher than it was this morning.